CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 4 Planned sale EVP, General Counsel sold 6,685 shares at $8.28 ($55,352)
- 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,982 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 43,948 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Executive Officer gave up 14,111 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SD Other Specialized Disclosure
- 8-K Event Material agreement
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 4 Grant or award Director acquired 859 shares (grant or award)
- 4 Grant or award Director acquired 4,140 shares (grant or award)
- 4 Grant or award Director acquired 7,812 shares (grant or award)
- 4 Grant or award Director acquired 3,906 shares (grant or award)
Page 13 of 121 · 2,419 filings